159922-50-6

Basic information

• Product Name: 4-METHOXYPHENYL 2,6-DI-O-BENZYL-BETA-D-GALACTOPYRANOSIDE
• Synonyms: 4-METHOXYPHENYL 2,6-DI-O-BENZYL-BETA-D-GALACTOPYRANOSIDE;4-Methoxyphenyl2,6-di-O-benzyl-b-D-galactopyranose;4-Methoxyphenyl 2,6-Di-O-benzyl-β-D-glucopyranoside;4-Methoxyphenyl 2,6-di-O-benzyl-b-D-galactopyranoside;4-Methoxyphenyl 2,6-Di-O-benzyl-β-D-galactopyranoside;4-Methoxyphenyl 2,6-Di-O-benzyl-β(2R,3R,4S,5R,6S)-5-(Benzyloxy)-2-((benzyloxy)methyl)-6-(4-methoxyphenoxy)tetrahydro-2H-pyran-3,4-diol
• CAS NO: 159922-50-6
• Molecular Formula: C₂₇H₃₀O₇
• Molecular Weight: 466.52
• Product Categories: Biochemistry;Galactose;Glycosides;O-Substituted Sugars;Sugars
• Mol File: 159922-50-6.mol

Chemical Properties

• Melting Point: 113 °C
• Boiling Point: 641.144oC at 760 mmHg
• Flash Point: 341.552oC
• Appearance: /
• Density: 1.279g/cm3
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: -1 ° (C=1, CHCl3)
• Storage Temp.: Freezer
• Solubility: slightly sol. in Chloroform
• PKA: 12.83±0.70(Predicted)
• CAS DataBase Reference: 4-METHOXYPHENYL 2,6-DI-O-BENZYL-BETA-D-GALACTOPYRANOSIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-METHOXYPHENYL 2,6-DI-O-BENZYL-BETA-D-GALACTOPYRANOSIDE(159922-50-6)
• EPA Substance Registry System: 4-METHOXYPHENYL 2,6-DI-O-BENZYL-BETA-D-GALACTOPYRANOSIDE(159922-50-6)

Safety Data

• Hazardous Substances Data: 159922-50-6(Hazardous Substances Data)

Usage

Chemical Properties

White to light yellow solid

InChI:InChI=1/C27H30O7/c1-30-21-12-14-22(15-13-21)33-27-26(32-17-20-10-6-3-7-11-20)25(29)24(28)23(34-27)18-31-16-19-8-4-2-5-9-19/h2-15,23-29H,16-18H2,1H3/t23-,24+,25+,26-,27-/m1/s1

Upstream product

• 100-39-0 benzyl bromide 
• 4163-60-4 β-D-galactose peracetate 
• 150-76-5 4-methoxy-phenol 
• 3150-20-7 4-methoxyphenyl β-D-galactopyranoside 
• 159922-67-5 4-methoxyphenyl 3,4-O-isopropylidene-β-D-galactopyranoside 
• 2872-65-3 4-methoxyphenyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside 
• 159922-68-6 4-methoxyphenyl 2,6-di-O-benzyl-3,4-O-isopropylidene-β-D-galactopyranoside 

Downstream Products

• 159922-51-7 C₇₉H₈₁NO₁₅S 
• 1104513-35-0 p-methoxyphenyl 4-O-acetyl-2,6-di-O-benzyl-β-D-galactopyranoside 
• 635684-68-3 4-methoxyphenyl 4-O-benzoyl-2,6-di-O-benzyl-β-D-galactopyranoside 

Relevant articles and documents

Total synthesis of sulfated glycosphingolipid SM1a, a kind of human epithelial carcinoma antigen

A highly efficient and practical total synthesis of the sulfated ganglioside SM1a, a kind of human epithelial carcinoma antigen identified in mammalian kidney, has been accomplished for the first time. The characteristic sequence of SM1a, β-D-Galp-(1→3)-β

Chemical synthesis of a tetrasaccharide related to the exocellular polysaccharide from Rhodococcus sp. RHA1

Chemical synthesis of the tetrasaccharide related to the exocellular polysaccharide from Rhodococcus sp. RHA1 is reported. The stereoselective glycosylations were achieved by activation of the thioglycoside donors using N-iodosuccinimide in the presence of La(OTf)3 varying temperature per the need of 1,2-cis or 1,2-trans glycosylations. The target tetrasaccharide is reported in the form of its p-methoxyphenyl glycoside that can be cleaved selectively from the per-O-acetylated derivative allowing further glycoconjugate formation using trichloroacetimidate chemistry.

Synthesis of some blocked di- and trisaccharide derivatives related to the repeating unit of the O-antigen from Shigella dysenteriae type 3 in the form of their glycosides

Starting from D-galactose and D-galactosamine hydrochloride, two new monosaccharide synthons namely 2-(trimethylsilyl)ethyl 4-O-acetyl-2,6-di-O- benzyl-β-D-galactopyranoside 2 and phenyl 3-O-acetyl-4,6-O-benzylidene-2- deoxy-2-phthalimido-1-thio-β-D-galac

Efficient synthesis of two HNK-1 related pentasaccharides

Two pentasaccharides, representative of those found on complex N-glycans, were synthesized for use as potential substrates for sulfotransferases. The synthesis was achieved by the addition of a disaccharide donor β-D-GlcA(1→3)α-D-Gal-trichloroacetimidate

SYNTHESIS OF HUMAN M BLOOD GROUP ANTIGENIC GLYCOPEPTIDE

A first total synthesis of terminal glycoheptapeptide of human glycophorin AM was accomplished by solution phase peptide condensation utilizing the tetrasaccharide-linked amino acid building blocks designed for Fmoc strategy.